预测IA期肺腺癌淋巴血管侵犯:基于CT的分类回归树模型
该多中心队列研究纳入行手术切除且术前有CT检查的临床IA期肺腺癌患者,构建基于CT的分类回归树模型(LVI-CART)预测淋巴血管侵犯,内部队列525例建模,外部队列115例和公共队列57例验证,AUC分别为0.719、0.756和0.835,预测LVI阳性与较差的无复发生存和总生存独立相关。
要点
- LVI-CART模型仅基于肿瘤直径和结节类型两个CT特征预测淋巴血管侵犯。
- 模型在内部验证集、外部验证集和测试集的AUC分别为0.719、0.756和0.835。
- 预测LVI阳性与1年、3年无复发生存及1年、3年、5年总生存独立相关(均P<0.05)。
核心结论
- LVI-CART模型可用于术前预测临床IA期肺腺癌患者的淋巴血管侵犯,并识别预后较差的患者,该模型简单且易于应用于风险分层。
研究设计与样本
- 多中心队列研究,内部队列525例用于构建LVI-CART模型,外部队列115例和公共队列57例用于验证模型预测性能,患者均接受手术切除且术前有CT检查。
诊断标准与关键数值
- LVI-CART模型包含直径和结节类型两个特征,预测病理LVI的AUC在内部验证集为0.719、外部验证集为0.756、测试集为0.835。
临床应用与阅片要点
- LVI-CART模型为临床医生提供了一种易于使用的方法,用于术前识别临床IA期肺腺癌中LVI阳性的患者,并为全面评估患者生存风险提供框架。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Lymphovascular invasion (LVI) is a significant histopathological marker associated with poor prognosis in patients. However, there is a notable lack of reliable, non-invasive preoperative tools to predict LVI accurately.
PURPOSE: To develop and validate a computed tomography (CT)-based classification and regression tree (CART) model for the preoperative prediction of LVI in patients with clinical stage IA lung adenocarcinoma (LUAD).
MATERIALS AND METHODS: This multicenter cohort study recruited patients who underwent resection and had a preoperative CT examination. An internal cohort (n = 525) is included to construct the LVI classification and regression tree model (LVI-CART). An external cohort (n = 115) and a public cohort (n = 57) are then used to fully validate the predictive performance of the LVI-CART. Kaplan-Meier survival analysis and univariable Cox regression analyses were conducted to investigate the relationship between predicted LVI status and survival.
RESULTS: The LVI-CART model includes two features, diameter and nodule type, and shows acceptable performance in predicting pathological LVI, with area under the curve values of 0.719, 0.756, and 0.835 in the internal validation set, external validation set and test set, respectively. A predicted LVI positive relative to the median value in the outcomes cohort was found to be independently associated with 1-, 3-year RFS and 1-, 3-, 5-year OS (all p-values < 0.05).
CONCLUSIONS: The LVI-CART model could be used to preoperatively predict LVI and identify patients with poor prognosis in clinical IA LUAD. The model is like to be simple and easily applicable to risk stratification.
KEY POINTS: Question Lymphovascular invasion is a critical histopathological indicator of poor prognosis, necessitating reliable non-invasive preoperative predictive tools. Findings The classification and regression tree model for predicting lymphovascular invasion (LVI-CART) model demonstrates adequate predictive ability for pathological LVI, portending poor recurrence-free and overall survival. Clinical relevance The LVI-CART model provides clinicians with an easy-to-use method for preoperative identification of patients with clinical stage IA lung adenocarcinoma who are LVI-positive. It also provides a framework for a comprehensive assessment of patient survival risk.
引用
- Chen L, Su Y, Huang Y, et al. Predicting lymphovascular invasion in stage IA lung adenocarcinoma: a CT-based classification and regression tree model. Eur Radiol. 2025. PMID: 40251442. doi:10.1007/s00330-025-11593-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。